ANGELA KHAN: Open Payments
NPI 1235836396 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 16 payments from 8 companies in 2025. Trend: 2023 $618 · 2024 $569 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $103 |
| Novo Nordisk Inc | 4 | $73 |
| ABBVIE INC. | 1 | $29 |
| MicroTransponder, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Boston Scientific Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: EVENITY, Ozempic, OTEZLA, QULIPTA, Veozah, WATCHMAN FLX, Rybelsus, REPATHA.
Industry payments across FL — which companies pay providers there.
